製品番号: HY-149843

LC-MB12

カスタマーレビュー

Based on 1 Customer Validation

LC-MB12 is an orally active PROTAC compound targets FGFR2 degradation with a DC₅₀ of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity.
(Pink: FGFR2 ligand (HY-160013); Blue: Cereblon ligand (HY-W069604); Black: linker (HY-Y1176)).

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 98.10%
CAS 番号: 2828438-38-4
分子式: C₄₃H₄₄Cl₂N₁₀O₈
分子量:899.78

保管条件:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

LC-MB12 構造式

CAS 番号: 2828438-38-4

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体外実験
- 体内実験
化学情報
溶剤 & 溶解度
- 体外
純度とドキュメンテーション
参考文献
Help & FAQs
関連分類
Bioz

生物活性

製品説明

LC-MB12 is an orally active PROTAC compound targets FGFR2 degradation with a DC₅₀ of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity^[1]. (Pink: FGFR2 ligand (HY-160013); Blue: Cereblon ligand (HY-W069604); Black: linker (HY-Y1176)).

IC₅₀ & Target

FGFR2

11.8 nM (DC₅₀)

PROTACs アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
BaF3	IC₅₀	10.3 nM Compound: LC-MB12	Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR2 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR2 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
BaF3	IC₅₀	125.2 nM Compound: LC-MB12	Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR1 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR1 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
BaF3	IC₅₀	139.2 nM Compound: LC-MB12	Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR3 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR3 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
BaF3	IC₅₀	>10000 nM Compound: LC-MB12	Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR4 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against mouse BaF3 cells expressing Tel-FGFR4 assessed as cell growth inhibition measured after 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
HEK-293T	IC₅₀	>10000 nM Compound: LC-MB12	Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against human HEK293T cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
KATO III stomach cancer cell line	IC₅₀	29.1 nM Compound: LC-MB12	Antiproliferative activity against human KATO III stomach cancer cell line assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against human KATO III stomach cancer cell line assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
MV4-11	IC₅₀	>10000 nM Compound: LC-MB12	Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
NCI-H1975	IC₅₀	>10000 nM Compound: LC-MB12	Antiproliferative activity against human NCI-H1975 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against human NCI-H1975 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
NCI-H716	IC₅₀	3.2 nM Compound: LC-MB12	Antiproliferative activity against human NCI-H716 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against human NCI-H716 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]
SNU-16	IC₅₀	3.7 nM Compound: LC-MB12	Antiproliferative activity against human SNU-16 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay Antiproliferative activity against human SNU-16 cells assessed as reduction in cell viability measured for 72 hrs by celltiter-glo reagent based assay	[PMID: 37220310]

体外実験

LC-MB12 (0.5-10,000 nM, 3-12 hours) degrades FGFR2 in a time-dependent manner in KATO III, with a DC₅₀ of 11.8 nM.
LC-MB12 (100 nM, 6 hours) degrades FGFR2 to 77% in KATO III and 43% in NCI-H1581^[1].
LC-MB12 (1-10000 nM, 72 hours) inhibits the growth of KATO III, SNU-16, and NCI-H716 significantly with IC₅₀s of 29.1 nM, 3.7 nM and 3.2 nM, respectively, and induces KATO III G0/G1 phase arrest^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

KATO III, SNU-16, NCI-H716
Concentration:

0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM
Incubation Time:

72 h
Result:

Inhibited cell growth with IC₅₀s value of 29.1 nM (KATO III); 3.7 nM (SNU-16); 3.2 nM (NCI-H716).

Cell Cycle Analysis^[1]

Cell Line:

KATO III
Concentration:

29.1 nM
Incubation Time:

72 h
Result:

Induced G0/G1 cycle arrest.

Immunofluorescence^[1]

Cell Line:

KATO III
Concentration:

100 nM
Incubation Time:

3 h, 6 h
Result:

Promoted FGFR2 was relocated from the cell membrane to intracellular vesicles after treated for 3 or 6 h. Induced receptor internalization and re-localization to the perinuclear section after 6 h treatment.

Western Blot Analysis^[1]

Cell Line:

KATO III, NCI-H1581
Concentration:

0.5 nM, 1.5 nM, 4.3 nM, 13 nM, 41 nM, 123 nM, 370 nM, 1111 nM, 3333 nM, 10000 nM
Incubation Time:

6 h
Result:

Degraded FGFR2 with a DC₅₀ of 11.8 nM and D _max of ~80% after 6 h of treatment.
Showed time-dependent effect on degradation,with a detectable reduction in FGFR2 levels after 3 h of treatment and ~90% degradation after 12 h.
Degraded of FGFR2 in KATO by 77%, and in NCI-H1581 by 43% after 100 nM treatment for 6 h.

体内実験

LC-MB12 (20 mg/kg/day, p.o., 15 days) inhibits tumor growth to 63.1% in SNU-16 xenograft models of nude mice^[1].
LC-MB12 (20 mg/kg, p.o.) shows fast absorption (C_max: 2.6 h) and orally bioavailable (F: 13%) in mice^[1].
LC-MB12 (20 mg/kg, p.o., 30 days) is well tolerated and has no apparent hepatotoxicity or nephrotoxicity in mice^[1].

In Vivo PK Properties of LC-MB12^[1]

parameter	T_1/2	T_max (ng•h/mL)	C_max	AUC_(0-∞)1/2	V_ss (h)	CL	F
unit	h	h	ng/mL	h^*ng/mL	mL/kg	mL/h/kg	%
iv (3 mg/kg)	0.97	0.083	655.29	421.61	6233.19	7289.12	/
po (20 mg/kg)	1.47	2.67	82.07	387.27	/	/	13.07

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

SNU-16 xenografted in BALB/c-nu mice^[1].
Dosage:

20 mg/kg/day
Administration:

oral administration (p.o.) 15 days
Result:

Achieved 63.1% tumor growth inhibition innocuously.
Inhibited FGFR phosphorylation and total FGFR2 protein and decreased phosphorylation levels of downstream pPLCγ and ERK1/2.

化学情報

CAS 番号 2828438-38-4
性状 Solid
分子量 899.78
分子式 C₄₃H₄₄Cl₂N₁₀O₈
Color Light yellow to yellow
SMILES

O=C(N(C)C1=CC(NC2=CC=C(N3CCN(CC3)C(C4CCN(CC4)C5=CC=C6C(N(C7C(NC(CC7)=O)=O)C(C6=C5)=O)=O)=O)C=C2)=NC=N1)NC8=C(Cl)C(OC)=CC(OC)=C8Cl
輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : 130 mg/mL (144.48 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

1.1114 mL

5.5569 mL

11.1138 mL

5 mM

0.2223 mL

1.1114 mL

2.2228 mL

10 mM

0.1111 mL

0.5557 mL

1.1114 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (276 KB)
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Ma L, et al. Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer. J Med Chem. 2023 Jun 8;66(11):7438-7453. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	1.1114 mL	5.5569 mL	11.1138 mL	27.7846 mL
	5 mM	0.2223 mL	1.1114 mL	2.2228 mL	5.5569 mL
	10 mM	0.1111 mL	0.5557 mL	1.1114 mL	2.7785 mL
	15 mM	0.0741 mL	0.3705 mL	0.7409 mL	1.8523 mL
	20 mM	0.0556 mL	0.2778 mL	0.5557 mL	1.3892 mL
	25 mM	0.0445 mL	0.2223 mL	0.4446 mL	1.1114 mL
	30 mM	0.0370 mL	0.1852 mL	0.3705 mL	0.9262 mL
	40 mM	0.0278 mL	0.1389 mL	0.2778 mL	0.6946 mL
	50 mM	0.0222 mL	0.1111 mL	0.2223 mL	0.5557 mL
	60 mM	0.0185 mL	0.0926 mL	0.1852 mL	0.4631 mL
	80 mM	0.0139 mL	0.0695 mL	0.1389 mL	0.3473 mL
	100 mM	0.0111 mL	0.0556 mL	0.1111 mL	0.2778 mL

Keywords

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

LC-MB12

Protein Tyrosine Kinase Compound Library

Anti-Cancer Compound Library

Angiogenesis-Related Compound Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

PROTAC Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Protein Kinase Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

Posttranslational Modification Library

PROTACs アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

LC-MB12

Protein Tyrosine Kinase Compound Library

Anti-Cancer Compound Library

Angiogenesis-Related Compound Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

PROTAC Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Protein Kinase Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

Posttranslational Modification Library

PROTACs アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

LC-MB12 関連分類

HY-149843 関連分類